InMed Pharmaceuticals Inc. (FRA:MWG)

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had revenue of $1.12M USD in the quarter ending September 30, 2025, a decrease of -11.43%. This brings the company's revenue in the last twelve months to $4.80M, down -3.27% year-over-year. In the fiscal year ending June 30, 2025, InMed Pharmaceuticals had annual revenue of $4.94M with 7.50% growth.

• Revenue (ttm): $4.80M
• Revenue Growth: -3.27%
• P/S Ratio: 0.90
• Revenue / Employee: $369.09K
• Employees: 13
• Market Cap: 3.66M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	4.94M	344.90K	7.50%
Jun 30, 2024	4.60M	462.17K	11.18%
Jun 30, 2023	4.14M	3.05M	279.61%
Jun 30, 2022	1.09M	-	-
Jun 30, 2021	-	-	-